Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report ; volume:11 ; number:1 ; day:9 ; month:4 ; year:2017 ; pages:1-4 ; date:12.2017
Journal of medical case reports ; 11, Heft 1 (9.4.2017), 1-4, 12.2017
- Keyword
-
Kardiovaskuläre Krankheit
- Creator
-
Scarano, Michele
- Contributor
-
Casale, Matteo
Mantini, Cesare
Imbalzano, Egidio
Consorti, Cristiana
Clemente, Daniela
Dattilo, Giuseppe
SpringerLink (Online service)
- DOI
-
10.1186/s13256-017-1249-8
- URN
-
urn:nbn:de:1111-201704212838
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Scarano, Michele
- Casale, Matteo
- Mantini, Cesare
- Imbalzano, Egidio
- Consorti, Cristiana
- Clemente, Daniela
- Dattilo, Giuseppe
- SpringerLink (Online service)
Other Objects (12)
Overcoming barriers for left atrial appendage thrombus: a systematic review of left atrial appendage closure
Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
Impact of left atrial appendage morphology on thrombus formation in TAVI patients with atrial fibrillation
Impact of left atrial appendage morphology on thrombus formation after successful left atrial appendage occlusion: Assessment with cardiac-computed-tomography
Diagnosis of left atrial appendage thrombus in patients with atrial fibrillation: delayed contrast-enhanced cardiac CT
Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation
Left atrial appendage thrombus; young or old? Role of CMR in definition
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Rivaroxaban versus warfarin for the management of left ventricle thrombus
Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation
Different scanning protocol to assess left atrial appendage thrombus in patients with atrial fibrillation by cardiovascular computed tomography
Overcoming barriers for left atrial appendage thrombus: a systematic review of left atrial appendage closure
Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
Impact of left atrial appendage morphology on thrombus formation in TAVI patients with atrial fibrillation
Impact of left atrial appendage morphology on thrombus formation after successful left atrial appendage occlusion: Assessment with cardiac-computed-tomography
Diagnosis of left atrial appendage thrombus in patients with atrial fibrillation: delayed contrast-enhanced cardiac CT
Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation
Left atrial appendage thrombus; young or old? Role of CMR in definition
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Rivaroxaban versus warfarin for the management of left ventricle thrombus
Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation
Different scanning protocol to assess left atrial appendage thrombus in patients with atrial fibrillation by cardiovascular computed tomography
Overcoming barriers for left atrial appendage thrombus: a systematic review of left atrial appendage closure
Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
Impact of left atrial appendage morphology on thrombus formation in TAVI patients with atrial fibrillation
Impact of left atrial appendage morphology on thrombus formation after successful left atrial appendage occlusion: Assessment with cardiac-computed-tomography
Diagnosis of left atrial appendage thrombus in patients with atrial fibrillation: delayed contrast-enhanced cardiac CT
Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation
Left atrial appendage thrombus; young or old? Role of CMR in definition
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Rivaroxaban versus warfarin for the management of left ventricle thrombus
Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation